Indivior PLC (LON:INDV – Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 712.52 ($9.03) and traded as high as GBX 787.50 ($9.98). Indivior shares last traded at GBX 769 ($9.75), with a volume of 273,799 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,500 ($19.01) target price on shares of Indivior in a research note on Thursday, September 5th.
Check Out Our Latest Report on Indivior
Indivior Stock Performance
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- How to invest in marijuana stocks in 7 steps
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Dividend Payout Ratio Calculator
- Applied Materials Market Capitulates: Now is the Time to Buy
- What is a Stock Market Index and How Do You Use Them?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.